The WATCHMAN implant provides an alternative treatment to reduce stroke risk for individuals ... “We consider it a privilege ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

China: The RESCUE BT trial found that intravenous (IV) tirofiban administered before endovascular thrombectomy significantly ...

China: A recent secondary analysis of the CATIS-2 randomized clinical trial has revealed that early initiation of ...

Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and long-term management of patients with Kawasaki ... the Council on ...

rigorous scientific investigations are necessary to establish clear clinical guidelines and optimize bloodletting for heat stroke treatment. Integrating this therapy within modern healthcare could ...

“In patients with AF at low risk of stroke, anticoagulation with daily rivaroxaban does ... Modified intention-to-treat (ITT) ...

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...